Mass producible and biocompatible microneedle patch and functional verification of its usefulness for transdermal drug delivery

The key issues in the development of a microneedle patch as a tool for transdermal drug delivery are safety and delivery performance in addition to economical production. In this paper, novel fabrication methods for an inexpensive microneedle patch made of biocompatible polymer are reported, along with functional verifications for the fabricated microneedle patch through animal models. We combined the merits of in-line microneedles, i.e., easy and economical production, with the superior performance of two-dimensionally arrayed microneedles. One-dimensionally fabricated microneedles were assembled to make two-dimensionally arrayed patches to attain our goal. First, we fabricated strips with one-dimensionally arrayed microneedles through deep X-ray lithography on polymethylmethacrylate or another negative photoresist, SU-8, with sharply reduced exposure time. Second, we assembled microneedle strips to make two-dimensionally arrayed microneedles, which we utilized further for fabrication of molding masters. Finally, we prepared microneedle patches made of polycarbonate by hot embossing with these masters. We then demonstrated the actual delivery of exogenous materials through application on skin via animal experiments, and we found no detectable side effects such as inflammation or allergic reactions at the site of application.

[1]  G. Cevc Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[2]  Manhee Han,et al.  A novel fabrication process for out-of-plane microneedle sheets of biocompatible polymer , 2007 .

[3]  M. Roberts,et al.  Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? , 2004, Current drug delivery.

[4]  M. Cormier,et al.  Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.

[5]  Wijaya Martanto,et al.  Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.

[6]  J. Braybrook,et al.  Biocompatibility assessment of medical devices and materials , 1997 .

[7]  Gabi Gruetzner,et al.  SU-8 based deep x-ray lithography/LIGA , 2003, SPIE MOEMS-MEMS.

[8]  P. Coulie,et al.  T-cell responses of vaccinated cancer patients. , 2003, Current opinion in immunology.

[9]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[10]  Véronique Préat,et al.  Skin electroporation for transdermal and topical delivery. , 2004, Advanced drug delivery reviews.

[11]  C. Akdis,et al.  Immune regulation in atopic dermatitis. , 2000, Current opinion in immunology.

[12]  N. Kollias,et al.  Transdermal drug delivery with a pressure wave. , 2004, Advanced drug delivery reviews.

[13]  Aarti Naik,et al.  Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.

[14]  C. Cremers,et al.  SU-8 as resist material for deep X-ray lithography , 2001 .

[15]  L. Gissmann,et al.  Transcutaneous immunization in mice: Induction of T‐helper and cytotoxic T lymphocyte responses and protection against human papillomavirus–induced tumors , 2006, International journal of cancer.

[16]  P. Gregersen,et al.  Cerebral Ischemia Enhances Polyamine Oxidation: Identification of Enzymatically Formed 3-Aminopropanal as an Endogenous Mediator of Neuronal and Glial Cell Death , 1998, The Journal of experimental medicine.

[17]  Fabrication of high-aspect-ratio nano structures using a nano x-ray shadow mask , 2008 .

[18]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[19]  N. Romani,et al.  Langerhans cells – dendritic cells of the epidermis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  Seung S. Lee,et al.  A novel method of microneedle array fabrication using inclined deep x-ray exposure , 2006 .

[21]  S. Plotkin,et al.  Vaccines: past, present and future , 2005, Nature Medicine.

[22]  Mark R Prausnitz,et al.  Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Mahmoud Ameri,et al.  Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Sang Jun Moon,et al.  A novel fabrication method of a microneedle array using inclined deep x-ray exposure , 2005 .

[25]  Susumu Sugiyama,et al.  Plain-pattern to cross-section transfer (PCT) technique for deep x-ray lithography and applications , 2004 .

[26]  R. Steinman,et al.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.

[27]  M. Allen,et al.  Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.

[28]  Gary P. Martin,et al.  Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects , 2006, Drug delivery.

[29]  E. Touitou,et al.  Drug delivery across the skin , 2002, Expert opinion on biological therapy.

[30]  P. McNally,et al.  A comparative study of Pd/Sn/Au, Au/Ge/Au/Ni/Au, Au-Ge/Ni and Ni/Au-Ge/Ni ohmic contacts to n-GaAs , 1998 .

[31]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[32]  W. R. Runyan,et al.  Semiconductor integrated circuit processing technology , 1990 .

[33]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Trinchieri,et al.  IL-12 synthesis by human Langerhans cells. , 1996, Journal of immunology.

[35]  D. Woodland Cell-mediated immunity to respiratory virus infections. , 2003, Current opinion in immunology.

[36]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.